Mirae Asset Global ETFs Holdings’s Phathom Pharmaceuticals PHAT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PHAT Stock Details PHAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$246K	Buy	22,647 +915	+4%	+$10.4K	﹤0.01%	2380
2026 Q1	$241K	Buy	21,732 +3,272	+18%	+$41.3K	﹤0.01%	2255
2025 Q4	$306K	Sell	18,460 -942	-5%	-$13.5K	﹤0.01%	2143
2025 Q3	$228K	Sell	19,402 -3,932	-17%	-$40.6K	﹤0.01%	2257
2025 Q2	$224K	Buy	23,334 +171	+0.7%	+$946	﹤0.01%	2221
2025 Q1	$145K	Buy	23,163 +1,014	+5%	+$6.16K	﹤0.01%	2471
2024 Q4	$180K	Buy	22,149 +3,408	+18%	+$42.2K	﹤0.01%	2441
2024 Q3	$339K	Buy	18,741 +2,471	+15%	+$34.5K	﹤0.01%	2106
2024 Q2	$168K	Buy	+16,270	New	+$168K	﹤0.01%	2345

Other funds holding PHAT

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PHAT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Phathom Pharmaceuticals (PHAT) stake by 4.2% in Q2 2026, buying an estimated $10.4K and bringing the position to 22,647 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #2380.

Mirae Asset Global ETFs Holdings first reported a position in PHAT in Q2 2024 and has held it in 9 quarters since. The position peaked at $339K in Q3 2024. 161 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

Mirae Asset Global ETFs Holdings held 22,647 shares of Phathom Pharmaceuticals worth $246K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 915 Phathom Pharmaceuticals shares in Q2 2026, an estimated $10.4K.
Phathom Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2380 holding.
Mirae Asset Global ETFs Holdings first reported a position in Phathom Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Phathom Pharmaceuticals position peaked at $339K in Q3 2024.
161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.